Two major proteoglycan constituents (designated F1 and F2) of the cell wall of Candida albicans were separated by ion-exchange chromatography from a crude carbohydrate-rich extract (GMP), and investigated for their chemical and molecular composition, antigenicity and immunomodulatory properties in cultures of human peripheral blood mononuclear cells (PBMC). Both fractions consisted predominantly of Periodic acid-Schiff (PAS) and concanavalin A (Con A)-reactive material consisting of >90% mannose, 3·5% protein and small amounts of phosphorus; each was recognized by an anti-Candida rabbit serum as well as by a monoclonal antibody (mAb AF1) directed against an oligosaccharide epitope present on the fungal cell surface. When F1 and F2 were subjected to SDS-PAGE, transblotted and stained with enzyme-conjugated mAb AF1 or Con A, most of the antibody or lectin bound to high molecular mass (> 200 kDa) polydisperse material, some of which was present in F2 (as in the starting GMP extract) but absent in F1. This difference was also observed in PAS-stained gels of the two fractions. The F2, but not the F1, constituent was as active as the unfractionated GMP extract in inducing lymphoproliferation, production of the cytokines interleukin-2 and interferon-γ, and generation of cytotoxicity against a natural-killer-sensitive target cell line (K562). These immunomodulatory properties were, like those possessed by GMP, protease-sensitive and heat-stable. Treatment of PBMC cultures with a modulatory anti-T-cell receptor antibody abolished the lymphoproliferation induced by GMP and F2 but not that induced by phytohaemagglutinin, showing that the mannoprotein materials of C. albicans acted through interaction with the antigen receptor complex.
AlcoverA.,
RamarliD.,
RichardsonN. E.,
ChangH. S.,
ReinherzE. L.1987; Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways. Immunological Reviews 95:5–35
AusielloC. M.,
SpagnoliG. C.,
BoccaneraM.,
CasalinuovoI.,
MalavasiF.,
CascianiC. U.,
CassoneA.1986; Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. Journal of Medical Microbiology 22:195–202
AusielloC. M.,
PalmaC.,
SpagnoliG. C.,
PiazzaA.,
CascianiC. U.,
CassoneA.1989; Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin-2-activated killer cells. Cellular Immunology 121:349–356
CarrowE. W.,
DomerJ. E.1985; Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein. Infection and Immunity 49:172–181
CassoneA.,
MarconiP.,
BistoniF.,
MattiaE.,
SbaragliaG.,
GaraciE.,
BonmassarE.1981; Immunoadjuvant effect of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunology Immunotherapy 10:181–189
CassoneA.,
TorosantucciA.,
BoccaneraM.,
PellegriniG.,
PalmaC.,
MalavasiF.1988; Production and characterization of a monoclonal antibody to a cell surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. Journal of Medical Microbiology 27:233–238
DjeuJ. Y.,
BlanchardD. K.,
RichardsA. L.,
FriedmanH.1988; Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. Journal of Immunology 141:4047–4052
DomerJ. E.,
StashakP. W.,
ElkinsK.,
PrescottB.,
CaldesG.,
BakerP. J.1986; Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components. Cellular Immunology 101:403–414
DomerJ. E.,
ElkinsK. L.,
EnnistD. L.,
StashakP. W.,
GarnerR. E.,
BakerP. J.1987; Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein. Infection and Immunity 55:2619–2624
DomerJ.,
ElkinsK.,
EnnistD.,
BakerP.1988; Modulation of immune responses by surface polysaccharides of Candida albicans
. Reviews of Infectious Diseases 10:419–422
DuboisM.,
GillesK. A.,
HamiltonJ. K.,
RebersP. A.,
SmithF.1956; Colorimetric method for determination of sugars and related substances. Analytical Chemistry 28:350–356
DurandyA.,
FisherA.,
Le DeistF.,
DrouhetE.,
GriscelliC.1987; Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidosis. Journal of Clinical Immunology 7:400–409
GillisS.,
FermM. M.,
OuW.,
SmithK. A.1971; T cell growth factor: parameters of production and a quantitative microassay for activity. Journal of Immunology 120:2077–2085
MarconiP.,
CassoneA.,
BaccariniM.,
TissiL.,
GaraciE.,
BonmassarE.,
FratiL.,
BistoniF.1983; Relationship between tumor load, route of tumor inoculation and response to immunotherapy in murine lymphoma model. Journal of the National Cancer Institute 71:299–305
NakajimaT.,
BallouC. E.1974; Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation. Journal of Biological Chemistry 249:7679–7684
PodzorskiR. P.,
GrayG. R.,
NelsonR. D.1990; Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. Journal of Immunology 144:707–716
ScaringiL.,
MarconiP.,
BoccaneraM.,
TissiL.,
BistoniF.,
CassoneA.1988; Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage- mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. Journal of General Microbiology 134:1265–1274
ScaringiL.,
CornacchioneP.,
RosatiE.,
BoccaneraM.,
CassoneA.,
BistoniF.,
MarconiP.1990; Induction of LAK like cells in the peritoneal cavity of mice by inactivated Candida albicans
. Cellular Immunology 129:271–287
ShibataN.,
IchikawaT.,
TojoM.,
SuzukiS.1985; Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Archives of Biochemistry and Biophysics 243:338–348
ShibataN.,
KobayashiH.,
TojoM.,
SuzukiS.1986; Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH-B-792 strain by the action of Zymolyase-100T. Archives of Biochemistry and Biophysics 251:697–708
SpagnoliG. C.,
AusielloC. M.,
CasalinuovoI.,
AntonelliG.,
DianzaniF.,
CassoneA.1985; Candida albicans and a phosphorylated glucomannan protein fraction of its cell wall induce production of immune interferon by human peripheral blood mononuclear cells. IRCS Medical Science 13:1190–1191
TorosantucciA.,
BoccaneraM.,
CasalinuovoI.,
PellegriniG.,
CassoneA.1990; Differences in the antigenic expression of immunomodulatory mannoprotein constituents of yeast and mycelial forms of Candida albicans
. Journal of General Microbiology 136:1421–1428
WeinbergJ. B.,
HibbsJ. B.1979; Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans
. Journal of the National Cancer Institute 63:1273–1278
WojdaniA.,
GhoneumM.1987; In vivo augmentation of natural killer cell activity by Candida albicans
. International Journal of Immunopharmacology 9:827–832